Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 854 | 1,076 | 760 | 864 | 770 |
| Marketable Securities | 65 | 65 | 65 | 65 | 71 |
| Receivables | N/A | N/A | N/A | N/A | 12 |
| Inventories | 12 | 12 | 12 | N/A | N/A |
| Other current assets | 2,695 | 1,422 | 537 | 1,155 | 1,204 |
| TOTAL | $4,073 | $2,770 | $1,470 | $2,180 | $2,148 |
| Non-Current Assets | |||||
| PPE Net | 12,056 | 8,215 | 8,169 | 511 | 7,932 |
| Investments And Advances | 3,870 | 3,963 | 3,885 | 3,384 | 3,614 |
| Other Non-Current Assets | 1,178 | 1,293 | 1,353 | 1,465 | 769 |
| TOTAL | $17,104 | $13,471 | $13,406 | $5,360 | $12,315 |
| Total Assets | $21,176 | $16,241 | $14,876 | $7,540 | $14,463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 81 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 729 | 819 | 0 | 419 |
| Accrued Expenses | 3,991 | 4,291 | 3,827 | 3,509 | 3,633 |
| Other current liabilities | 1,283 | N/A | 81 | 854 | 80 |
| TOTAL | $6,508 | $6,533 | $6,731 | $6,558 | $6,316 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 217 | 295 | 291 | 324 | 261 |
| TOTAL | $176 | $219 | $189 | $259 | $168 |
| Total Liabilities | $6,684 | $6,751 | $6,919 | $6,816 | $6,484 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,301 | 23,542 | 16,773 | 15,778 | 12,975 |
| Common Shares | 24 | 20 | 15 | 14 | 13 |
| Retained earnings | -73,295 | -72,049 | -69,792 | -68,950 | -70,552 |
| Other shareholders' equity | 3,649 | 4,141 | 3,117 | 65 | 211 |
| TOTAL | $14,493 | $9,490 | $7,956 | $724 | $7,979 |
| Total Liabilities And Equity | $21,176 | $16,241 | $14,876 | $7,540 | $14,463 |